Prestige Consumer Healthcare (PBH) Cash from Operations (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Cash from Operations of 78287000.0 for Q4 2025, up 20.27% year-over-year from 65091000.0 in Q4 2024, and up 36.18% quarter-over-quarter from 57486000.0 in Q3 2025.
Prestige Consumer Healthcare (PBH) Cash from Operations (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Cash from Operations history runs 16 years deep, the most recent figure standing at 78287000.0 for Q4 2025.
- In Q4 2025, Cash from Operations rose 20.27% year-over-year to 78287000.0; the TTM figure through Dec 2025 stood at 276634000.0 (up 7.82% YoY), while the FY2025 annual figure was 251515000.0, up 1.04% from the prior year.
- Cash from Operations for Q4 2025 stood at 78287000.0, up from 57486000.0 in the prior quarter.
- The five-year high for Cash from Operations was 79013000.0 in Q2 2025, with the low at 48087000.0 in Q2 2023.
- The 5-year median for Cash from Operations is 62154000.0 (2023), against an average of 63197600.0.
- Peak annual rise in Cash from Operations reached 44.25% in 2025, while the deepest fall reached 17.64% in 2025.
- Prestige Consumer Healthcare's Cash from Operations stood at 66297000.0 in 2021, then declined by 17.13% to 54942000.0 in 2022, then soared by 30.09% to 71472000.0 in 2023, then dropped by 8.93% to 65091000.0 in 2024, then climbed by 20.27% to 78287000.0 in 2025.
- Business Quant data shows PBH's Cash from Operations at 78287000.0 in Q4 2025, 57486000.0 in Q3 2025, and 79013000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 78.29 Mn |
| Dec 31, 2025 | 78.29 Mn |
| Sep 30, 2025 | 57.49 Mn |
| Sep 30, 2025 | 57.49 Mn |
| Jun 30, 2025 | 79.01 Mn |
| Jun 30, 2025 | 79.01 Mn |
| Mar 31, 2025 | 61.85 Mn |
| Mar 31, 2025 | 61.85 Mn |
| Dec 31, 2024 | 65.09 Mn |
| Dec 31, 2024 | 65.09 Mn |
| Sep 30, 2024 | 69.80 Mn |
| Sep 30, 2024 | 69.80 Mn |
| Jun 30, 2024 | 54.78 Mn |
| Jun 30, 2024 | 54.78 Mn |
| Mar 31, 2024 | 66.91 Mn |
| Mar 31, 2024 | 66.91 Mn |
| Dec 31, 2023 | 71.47 Mn |
| Dec 31, 2023 | 71.47 Mn |
| Sep 30, 2023 | 62.46 Mn |
| Sep 30, 2023 | 62.46 Mn |